Kenneth Onu currently serves as a Principal Programme Officer, Therapeutics for the African Union Smart Safety Surveillance Programme at the African Union Development Agency – NEPAD based in Midrand Johannesburg, South Africa. Kenneth is responsible for developing and implementing therapeutics strategies for the AU-3S programme as workstream lead focusing on new and innovative medical products in priority disease areas with  proof of concept using cross-country adverse event following immunization reports associated with Covid-19 antivirals. He is also overseeing the development and implementation of a policy framework and governance structure for therapeutics safety surveillance as the AU-3S programme expands to a continental safety monitoring platform for Africa.

In addition, he also coordinates joint safety reviews and signal management for therapeutic products and facilitating the operationalization of the African Union Pharmacovigilance Risk Assessment Committee (AU-PRAC). Prior to joining AUDA-NEPAD, he worked across various regulatory functions with focus on quality and safety of medical products at the National Agency for Food and Drug Administration and Control (NAFDAC) Nigeria for 12 years.